Preclinical study findings point to new possibilities for strategies for treating metastatic TNBC patients for whom there are no specific therapies.
A gene expression program executed by neutrophils and a corresponding biomarker support tumor progression across human and murine tumors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results